Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.60 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.55 |
| ▸ | PKM | P14618 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | G6PD | P11413 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | CCR6 | P51684 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | CASP1 | P29466 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29752049 | 1.00 | CYP3A4 (0.60) | CYP3A4TSHRMAPK1ALDH1A1MAPT | |
| SCHEMBL10256689 | 0.89 | CYP3A4 (0.60) | CYP3A4TSHRMAPK1ALDH1A1MAPT | |
| SCHEMBL29673743 | 0.89 | CYP3A4 (0.60) | CYP3A4TSHRMAPK1ALDH1A1MAPT | |
| SCHEMBL5963088 | 0.86 | CYP3A4 (0.55) | CYP3A4TSHRMAPK1ALDH1A1MAPT | |
| SCHEMBL3077884 | 0.86 | ALDH1A1 (0.50) | CYP3A4TSHRMAPK1ALDH1A1MAPT | |
| SCHEMBL19307999 | 0.83 | ALDH1A1 (0.48) | CYP3A4TSHRMAPK1ALDH1A1MAPT | |
| SCHEMBL5884188 | 0.83 | CYP3A4 (0.52) | CYP3A4TSHRMAPK1ALDH1A1MAPT | |
| SCHEMBL29721080 | 0.83 | TSHR (0.60) | CYP3A4TSHRMAPK1ALDH1A1MAPT | |
| SCHEMBL94645 | 0.83 | TSHR (0.60) | CYP3A4TSHRMAPK1ALDH1A1MAPT | |
| SCHEMBL15449430 | 0.83 | ALDH1A1 (0.55) | CYP3A4TSHRMAPK1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 876 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116695435-A | Carbon fiber, preparation method thereof and composite material containing carbon fiber | 江苏君澄空间科技有限公司 | 2023-09-05 | — | — | CN | claimed |
| US-9745288-B2 | Compounds and methods for treating cancer by inhibiting the urokinase receptor | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2017-08-29 | — | — | US | claimed |
| US-20150051247-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER BY INHIBITING THE UROKINASE RECEPTOR | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION | 2015-02-19 | — | — | US | claimed |
| WO-2013025939-A2 | COMPOUNDS AND METHODS FOR TREATING CANCER BY INHIBITING THE UROKINASE RECEPTOR | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2013-02-21 | — | — | WO | claimed |
| US-7652089-B2 | Nanocomposite, nanocomposite electrolyte membrane and fuel using the same | SAMSUNG SDI CO., LTD. (KR) | 2010-01-26 | — | — | US | claimed |
| US-7419656-B2 | Mixture containing phenylenediamine compound | KAO CORPORATION (JP) | 2008-09-02 | — | — | US | claimed |
| US-20080176126-A1 | ELECTROLYTE MEMBRANE COMPRISING NANOCOMPOSITE ION COMPLEX, MANUFACTURING METHOD THEREOF, AND FUEL CELL INCLUDING THE SAME | SAMSUNG SDI CO, LTD. (KR) | 2008-07-24 | — | — | US | claimed |
| US-20070072982-A1 | Nanocomposite, nanocomposite electrolyte membrane and fuel using the same | SAMSUNG SDI CO., LTD. (KR) | 2007-03-29 | — | — | US | claimed |
| CN-1558898-A | Antiviral agent | ��Ұ����ҩ��ʽ���� | 2004-12-29 | — | — | CN | claimed |
| EP-1422218-A1 | ANTIVIRAL AGENT | SHIONOGI & CO., LTD. (JP) | 2004-05-26 | — | — | EP | claimed |
| US-4865619-A | Use, as a coupler, of 2,4-diamino-1,3-dimethoxybenzene or one of its salts, in combination with oxidation dye precursors, for dyeing human hair, hair dyeing composition containing the said coupler and process for preparing the said coupler | L'OREAL (FR) | 1989-09-12 | — | — | US | claimed |
| US-4865618-A | New chloro-meta-phenylenediamines, their use as couplers in the oxidation dyeing of keratinous fibres, dyeing compositions for hair containing these compounds and dyeing process using the said | L'OREAL (FR) | 1989-09-12 | — | — | US | claimed |
| EP-0295474-A1 | Chlorometaphenylenediamines, their use as coupling agents in oxydation colouring of keratinic fibres, colourity compositions for hair containing these compounds and colouring process using these compositions | L'OREAL (FR) | 1988-12-21 | — | — | EP | claimed |
| EP-0294669-A1 | Metaphenylendiamines, process for their preparation, intermediate compounds and use of these metaphenylendiamines as couplers in oxydative colouring of keratinic fibres especially of human hair | L'OREAL (FR) | 1988-12-14 | — | — | EP | claimed |
| US-4692166-A | OXIDATION COLOR DYES USED WITH DIAMINOBENZENES OR AMINO PHENOLS; MINIMIZATION OF RED HUE | L'OREAL (FR) | 1987-09-08 | — | — | US | claimed |
| US-4425132-A | HAIR DYES, APPLYING WITHOUT RINSING | L'OREAL (FR) | 1984-01-10 | — | — | US | claimed |
| US-4337061-A | NITRO DYES IN AQUEOUS SOLUTION | SOCIETE ANONYME DITE: L'OREAL (FR) | 1982-06-29 | — | — | US | claimed |
| US-4200432-A | HAIR DYES | L'OREAL (FR) | 1980-04-29 | — | — | US | claimed |
| US-3970459-A | Process for developing a direct reversal silver halide photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JA) | 1976-07-20 | — | — | US | claimed |
| US-3948596-A | Oxidation dye for keratinic fibers containing 2-halo-5-acetaminophenol as a coupler | SOCIETE ANONYME DITE: L'OREAL (FR) | 1976-04-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051247-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER BY INHIBITING THE UROKINASE RECEPTOR | PLAUR, PLAU, PLG | CYP3A4 4308/4885TSHR 1873/4885MAPK1 1646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.